161
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Which is responsible for target organ damage in masked hypertension? Is it an increase in blood pressure or a disruption of the circadian rhythm?

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 579-585 | Received 17 Mar 2021, Accepted 26 Mar 2021, Published online: 18 Apr 2021

References

  • Pena-Hernandez C, Nugent K, Tuncel M. Twenty-four-hour ambulatory blood pressure monitoring. J Prim Care Community Health. 2020;11:2150132720940519.doi:10.1177/2150132720940519.
  • Conen D, Bamberg F.Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens. 2008;26(7):1290–99.doi:10.1097/HJH.0b013e3282f97854.
  • Verdecchia P.Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35(3):844–51.doi:10.1161/01.HYP.35.3.844.
  • Hamadou B, Amougou SN, Tchuendem Y, Nganou-Gnindjio CN, Mfeukeu-Kuate L, Foka AJ, Tankeu AT, Jingi AM, Menanga AP, Kingue S.Prevalence and determinants of masked hypertension among obese individuals at the Yaoundé Central Hospital: a cross-sectional study in sub-Saharan Africa. Blood Press Monit. 2020;25(4):212–15.doi:10.1097/MBP.0000000000000457.
  • Leitão CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL.Masked hypertension, urinary albumin excretion rate, and echocardiographic parameters in putatively normotensive type 2 diabetic patients. Diabetes Care. 2007;30(5):1255–60.doi:10.2337/dc06-2131.
  • Tocci G, Presta V, Figliuzzi I, Attal La El Halabieh N, Battistoni A, Coluccia R, D’Agostino M, Ferrucci A, Volpe M.Prevalence and clinical outcomes of white-coat and masked hypertension: analysis of a large ambulatory blood pressure database. J Clin Hypertens (Greenwich). 2018;20(2):297–305.doi:10.1111/jch.13181.
  • Komori T, Eguchi K, Kabutoya T, Ishikawa J, Hoshide S, Kario K.Left ventricular diastolic function evaluated by the E/e’ ratio is impaired in patients with masked uncontrolled hypertension. Clin Exp Hypertens. 2014;36(8):538–44.doi:10.3109/10641963.2014.881839.
  • Oe Y, Shimbo D, Ishikawa J, Okajima K, Hasegawa T, Diaz KM, Muntner P, Homma S, Schwartz JE.Alterations in diastolic function in masked hypertension: findings from the masked hypertension study. Am J Hypertens. 2013;26(6):808–15.doi:10.1093/ajh/hpt021.
  • Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, Deo R, Fischer MJ, He J, Hsu CY, et al. Masked hypertension and elevated nighttime blood pressure in CKD: prevalence and association with target organ damage. Clin J Am Soc Nephrol. 2016;11(4):642–52.doi:10.2215/CJN.08530815.
  • Esme M, Asil S, Yavuz B, Balci C, Kılıç MK, Kızılarslanoğlu MC, Doğan Varan H, Tuna Doğrul R, Halil M, Cankurtaran M, et al. Masked hypertension is associated with end organ damage in geriatric age: geriatric MASked Hypertension and End organ damage (G-MASH-End organ Study). Blood Press. 2020;29(2):80–86.doi:10.1080/08037051.2019.1675475.
  • Ishikawa J, Hoshide S, Eguchi K, Schwartz JE, Pickering TG, Shimada K, Kario K.Masked hypertension defined by ambulatory blood pressure monitoring is associated with an increased serum glucose level and urinary albumin-creatinine ratio. J Clin Hypertens (Greenwich). 2010;12(8):578–87.doi:10.1111/j.1751-7176.2010.00286.x.
  • Gijón-Conde T, Graciani A, López-García E, Guallar-Castillón P, García-Esquinas E, Rodríguez-Artalejo F, Banegas JR.Short-term variability and nocturnal decline in ambulatory blood pressure in normotension, white-coat hypertension, masked hypertension and sustained hypertension: a population-based study of older individuals in Spain. Hypertens Res. 2017;40(6):613–19.doi:10.1038/hr.2017.9.
  • Tadic M, Cuspidi C, Celic V, Pencic B, Mancia G, Grassi G, Stankovic G, Ivanovic B. The prognostic effect of circadian blood pressure pattern on long-term cardiovascular outcome is independent of left ventricular remodeling. J Clin Med. 2019;8.
  • Hastings MH, Reddy AB, Maywood ES.A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649–61.doi:10.1038/nrn1177.
  • O’Brien E, Sheridan J, O’Malley K.Dippers and non-dippers. Lancet. 1988;2(8607):397.doi:10.1016/S0140-6736(88)92867-X.
  • Ohkubo T, Imai Y, Tsuji I, Nagai K, Watanabe N, Minami N, Kato J, Kikuchi N, Nishiyama A, Aihara A, et al. Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study. Am J Hypertens. 1997;10(11):1201–07.doi:10.1016/S0895-7061(97)00274-4.
  • Abdalla M, Caughey MC, Tanner RM, Booth JN 3rd, Diaz KM, Anstey DE, Sims M, Ravenell J, Muntner P, Viera AJ, et al. Associations of blood pressure dipping patterns with left ventricular mass and left ventricular hypertrophy in blacks: the Jackson Heart Study. J Am Heart Assoc. 2017;6(4):6.doi:10.1161/JAHA.116.004847.
  • Gavriilaki M, Anyfanti P, Nikolaidou B, Lazaridis A, Gavriilaki E, Douma S, Gkaliagkousi E.Nighttime dipping status and risk of cardiovascular events in patients with untreated hypertension: a systematic review and meta-analysis. J Clin Hypertens (Greenwich). 2020;22(11):1951–59.doi:10.1111/jch.14039.
  • Li J, Cao Y, Liu C, Li J, Yao F, Dong Y, Huang H.Diastolic reverse dipping pattern is the predictor for the echocardiographic changes in the untreated masked hypertensive patients. Am J Hypertens. 2019;32(6):588–96.doi:10.1093/ajh/hpz041.
  • Zhang DY, Cheng YB, Guo QH, Wang Y, Sheng CS, Huang QF, An DW, Li MX, Huang JF, Xu TY, et al. Subtypes of masked hypertension and target organ damage in untreated outpatients. Blood Press. 2020;29(5):299–307.doi:10.1080/08037051.2020.1763159.
  • Wei W, Tölle M, Zidek W, Van Der Giet M.Validation of the mobil-O-Graph: 24 h-blood pressure measurement device. Blood Press Monit. 2010;15(4):225–28.doi:10.1097/MBP.0b013e328338892f.
  • Whelton PK, Carey RM, Aronow WS, Casey DE Jr., Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.doi:10.1161/HYP.0000000000000065.
  • Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.doi:10.7326/0003-4819-150-9-200905050-00006.
  • Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005;18(12):1440–63.doi:10.1016/j.echo.2005.10.005.
  • Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A.Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22(2):107–33.doi:10.1016/j.echo.2008.11.023.
  • Trudel X, Brisson C, Gilbert-Ouimet M, Duchaine CS, Dalens V, Talbot D, Milot A.Masked hypertension incidence and risk factors in a prospective cohort study. Eur J Prev Cardiol. 2019;26(3):231–37.doi:10.1177/2047487318802692.
  • Cuspidi C, Sala C, Tadic M, Rescaldani M, Grassi G, Mancia G.Untreated masked hypertension and subclinical cardiac damage: a systematic review and meta-analysis. Am J Hypertens. 2015;28(6):806–13.doi:10.1093/ajh/hpu231.
  • Yılmaz Ö, Özkan S.Is masked hypertension an underlying cause of unexplained left ventricle hypertrophy? Clin Exp Hypertens. 2021;43(2):138–41.doi:10.1080/10641963.2020.1825729.
  • Özkan S, Yılmaz Ö, Yavuz B.Evaluation of atrial electromechanical properties in patients with masked hypertension. Clin Exp Hypertens. 2020;42(6):527–30.doi:10.1080/10641963.2020.1714644.
  • Tadic M, Cuspidi C, Radojkovic J, Rihor B, Kocijanic V, Celic V.Masked hypertension and left atrial dysfunction: a hidden association. J Clin Hypertens (Greenwich). 2017;19(3):305–11.doi:10.1111/jch.12901.
  • Bombelli M, Facchetti R, Mancia G, Grassi G.Big data and blood pressure control: insights from the PAMELA and BP-CARE Study Cohorts. Curr Hypertens Rep. 2018;20(10):82.doi:10.1007/s11906-018-0885-8.
  • Mancia G, Sega R, Bravi C, De Vito G, Valagussa F, Cesana G, Zanchetti A.Ambulatory blood pressure normality: results from the PAMELA study. J Hypertens. 1995;13(12):1377–90.doi:10.1097/00004872-199512000-00003.
  • Shimbo D, Newman JD, Schwartz JE.Masked hypertension and prehypertension: diagnostic overlap and interrelationships with left ventricular mass: the Masked Hypertension Study. Am J Hypertens. 2012;25(6):664–71.doi:10.1038/ajh.2012.15.
  • Sarıkaya S, Sahin S, Oztürk S, Akyol L, Altunkaş F, Karaman K, Alcelik A, Keser Yılmaz Y.Detection of atrial electrical and mechanical dysfunction in non-dipper pre-hypertensive subjects. Clin Exp Hypertens. 2014;36(7):465–70.doi:10.3109/10641963.2013.846362.
  • Ida T, Kusaba T, Kado H, Taniguchi T, Hatta T, Matoba S, Tamagaki K.Ambulatory blood pressure monitoring-based analysis of long-term outcomes for kidney disease progression. Sci Rep. 2019;9(1):19296.doi:10.1038/s41598-019-55732-4.
  • Kado H, Kusaba T, Matoba S, Hatta T, Tamagaki K.Normotensive non-dipping blood pressure profile does not predict the risk of chronic kidney disease progression. Hypertens Res. 2019;42(3):354–61.doi:10.1038/s41440-018-0155-9.
  • Kilic A, Baydar O.The relationship between diurnal blood pressure abnormalities and target organ damage in normotensive subjects. Which is more important? Increased blood pressure levels or circadian blood pressure abnormalities. Clin Exp Hypertens. 2020;42(3):244–49.doi:10.1080/10641963.2019.1619757.
  • Hermida RC, Ayala DE, Mojón A, Fernández JR.Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level–the “normotensive non-dipper” paradox. Chronobiol Int. 2013;30(1–2):87–98.doi:10.3109/07420528.2012.701127.
  • Presta V, Figliuzzi I, D’Agostino M, Citoni B, Miceli F, Simonelli F, Coluccia R, Musumeci MB, Ferrucci A, Volpe M, et al. Nocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension. J Clin Hypertens (Greenwich). 2018;20(9):1238–46.doi:10.1111/jch.13361.
  • Kang YY, Li Y, Huang QF, Song J, Shan XL, Dou Y, Xu XJ, Chen SH, Wang JG.Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension. J Hypertens. 2015;33(8):1580–87.doi:10.1097/HJH.0000000000000596.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.